44 related articles for article (PubMed ID: 8067718)
1. Plasma prolactin in patients with colorectal cancer.
Soroush AR; Zadeh HM; Moemeni M; Shakiba B; Elmi S
BMC Cancer; 2004 Dec; 4():97. PubMed ID: 15617576
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of preoperative HPR, LCR and CEA levels in colorectal cancer.
Huang D; Guo B; Zheng Z; Huang Y; Liu W
Minerva Pediatr (Torino); 2023 Oct; 75(5):758-760. PubMed ID: 37155215
[No Abstract] [Full Text] [Related]
3. Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review.
Bhardwaj M; Gies A; Werner S; Schrotz-King P; Brenner H
Clin Transl Gastroenterol; 2017 Nov; 8(11):e128. PubMed ID: 29189767
[TBL] [Abstract][Full Text] [Related]
4. IMMUNOBIOLOGICAL MONITORING OF VARIOUS GASTROINTESTINAL AND PRIMARY HEPATIC MALIGNANCIES.
Chopra GS; Mishra KB; Vohra LS; Jaiprakash MP; Bhardwaj JR
Med J Armed Forces India; 1997 Jul; 53(3):178-182. PubMed ID: 28769480
[TBL] [Abstract][Full Text] [Related]
5. At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.
Han ES; Lee HH; Lee JS; Song KY; Park CH; Jeon HM
J Gastric Cancer; 2014 Jun; 14(2):123-8. PubMed ID: 25061540
[TBL] [Abstract][Full Text] [Related]
6. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.
Qiu Y; Patwa TH; Xu L; Shedden K; Misek DE; Tuck M; Jin G; Ruffin MT; Turgeon DK; Synal S; Bresalier R; Marcon N; Brenner DE; Lubman DM
J Proteome Res; 2008 Apr; 7(4):1693-703. PubMed ID: 18311904
[TBL] [Abstract][Full Text] [Related]
7. Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer.
Chapman MA; Buckley D; Henson DB; Armitage NC
Br J Cancer; 1998 Nov; 78(10):1346-9. PubMed ID: 9823977
[TBL] [Abstract][Full Text] [Related]
8. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
[TBL] [Abstract][Full Text] [Related]
9. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
Grotowski M
Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer.
Eskelinen M; Pasanen P; Kulju A; Janatuinen E; Miettinen P; Poikolainen E; Tarvainen R; Nuutinen P; Pääkkönen M; Alhava E
Anticancer Res; 1994; 14(3B):1427-32. PubMed ID: 8067718
[TBL] [Abstract][Full Text] [Related]
11. Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?
Eskelinen M; Pasanen P; Janatuinen E; Pettersson N; Linnane A; Alhava E
Anticancer Res; 1995; 15(5B):2351-6. PubMed ID: 8572651
[TBL] [Abstract][Full Text] [Related]
12. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.
Huber K; Kirchheimer JC; Sedlmayer A; Bell C; Ermler D; Binder BR
Cancer Res; 1993 Apr; 53(8):1788-93. PubMed ID: 8467497
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
